<DOC>
	<DOCNO>NCT00031161</DOCNO>
	<brief_summary>This study determine safety dichloroacetate ( DCA ) low-tyrosine diet give without nitisinone ( NTBC ) child chronic lactic acidosis ( CLA ) .</brief_summary>
	<brief_title>Prevention Dichloroacetate Toxicity</brief_title>
	<detailed_description>DCA study treatment patient CLA , rare collection mitochondrial metabolism error cause cellular energy failure early death . DCA cause reversible liver peripheral nerve toxicity interrupt tyrosine heme metabolism . The inhibitory effect DCA mammalian tyrosine metabolism elicit biochemical change similar observe hereditary tyrosinemia type I ( HT ) . However , report study indicate substantial reduction biochemical clinical consequence HT may occur patient treat concomitantly low-tyrosine diet ( LTD ) chemical NTBC , inhibit early step tyrosine catabolism . Possibly , dietary pharmacologic intervention may mitigate prevent toxicity associate chronic DCA exposure . Patients visit Center 5 time 1-year period , usually 2 3 day per visit , extensive series clinical biochemical test . Visit 1 baseline examination blood urine chemistry educate patient LTD . This visit last approximately 7 day determine acceptable circulate tyrosine concentration LTD formula discharge . Patients provide tube take local laboratory every 2 week blood work . Patients readmitted 1 month determine adherence diet serum tyrosine level . Patients evidence dietary compliance , adverse effect , willingness continue place 1 2 treatment arm : DCA plus LTD plus placebo DCA plus LTD plus NTBC . Thereafter , patient return Months 5 , 9 , 13 , complete 1-year treatment phase . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Acidosis</mesh_term>
	<mesh_term>Acidosis , Lactic</mesh_term>
	<mesh_term>Nitisinone</mesh_term>
	<criteria>Inclusion criterion : Biochemical molecular genetic proof defect mitochondrial enzyme glucose metabolism oxidative phosphorylation . Clinical history consistent CLA ( e.g. , basal hyperlactatemia , strokelike episode , neuromuscular degeneration , seizure ) . Ability withstand 8hour fast ( 2 year old young ) 12hour fast without develop hypoglycemia ( blood glucose great equal 50 mg/dL ) . Exclusion criterion : Secondary lactic acidosis due impaired oxygenation circulation . Hyperlactatemia associate proven biotinidase deficiency enzyme deficiency gluconeogenesis . Primary , define organic acidurias lactic acidosis effective therapy available ( e.g. , propionic aciduria ) . Primary disorder amino acid metabolism . Primary disorder fatty acid oxidation . Malabsorption syndromes associate Dlactic acidosis . Renal insufficiency . Serum creatinine great 1.2 mg/g . Creatinine clearance less equal 60 mL/min . Primary hepatic disease unrelated chronic lactic acidosis . In patient pyruvate dehydrogenase enzyme complex deficiency , inability maintain diet great 50 % calorie fat without biological and/or neurological deterioration .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>January 2002</verification_date>
	<keyword>Tyrosine</keyword>
	<keyword>Diet</keyword>
	<keyword>2- ( 2-nitro-4-trifluoromethylbenzoyl ) -1,3-cyclohexanedione</keyword>
	<keyword>4-Hydroxyphenylpyruvate Dioxygenase</keyword>
	<keyword>Enzyme Inhibitors</keyword>
</DOC>